Page 16 - ப்ட் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ட் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ட் இன்க் Today - Breaking & Trending Today

Thermo Fisher to acquire CRO firm PPD for $17.4 B


Thermo Fisher to acquire CRO firm PPD for $17.4 B
Thermo Fisher to acquire CRO firm PPD for $17.4 B
15 April 2021 | News
Image credit- shutterstock.com
Thermo Fisher Scientific Inc. and PPD, Inc. have announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt.
This represents a premium of approximately 24% to the unaffected closing price of PPD s common stock on the Nasdaq as of Tuesday, April 13, 2021, or 32% to the 60-day VWAP inclusive of that date. ....

Marcn Casper , David Simmons , Thermo Fisher Laboratory Products , Thermo Fisher Scientific Inc , Ppd Inc , Services Segment , Thermo Fisher , Thermo Fisher Scientific , Laboratory Products , டேவிட் சிம்மன்ஸ் , தெர்மோ மீனவர் அறிவியல் இன்க் , ப்ட் இன்க் , சேவைகள் பிரிவு , தெர்மோ மீனவர் , தெர்மோ மீனவர் அறிவியல் , ஆய்வகம் ப்ராடக்ட்ஸ் ,

Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development -


What You Should Know:
– Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures.
– This is Medable’s third round of funding in less than a year, bringing total capital raised to more than $217 million. 
Global Decentralized Clinical Trial Platform
Founded in 2015 by Dr. Michelle Longmire and Tim Smith, Medable’s flexible and modular software platform enables clinical leaders to shift from clinic-centric to patient-centric research strategies. The platform provides a unified experience for patients and clinicians, enabling recruitment, remote screening, el ....

Tim Smith , Michelle Longmire , Medable Inc , Ppd Inc , Drug Development , Medable Raises , Expand Decentralized Clinical Trials Platform , Patient Centered Drug , Should Know , Palo Alto , Sapphire Ventures , Obvious Ventures , நேரம் ஸ்மித் , மைக்கேல் லாங்மயர் , ப்ட் இன்க் , மருந்து வளர்ச்சி , வேண்டும் தெரியும் , பாலோ ஆல்டோ , சபையர் முயற்சிகள் , வெளிப்படையானது முயற்சிகள் ,